{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:52:09Z","timestamp":1789185129912,"version":"build-2803163510"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["AI169181"],"award-info":[{"award-number":["AI169181"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66322-6","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:26:00Z","timestamp":1765358760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Structural insights into clonal restriction and diversity in T cell recognition of two immunodominant SARS-CoV-2 nucleocapsid epitopes"],"prefix":"10.1038","volume":"16","author":[{"given":"Ping","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8517-9075","authenticated-orcid":false,"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2860-8205","authenticated-orcid":false,"given":"Xichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6741-5943","authenticated-orcid":false,"given":"Shayana","family":"Saravanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-0871","authenticated-orcid":false,"given":"Ying-Wu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-3388","authenticated-orcid":false,"given":"Mostafa","family":"Elbahnasawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Ping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-0368","authenticated-orcid":false,"given":"Brian G.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-5875","authenticated-orcid":false,"given":"Roy A.","family":"Mariuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2086-0190","authenticated-orcid":false,"given":"Daichao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"66322_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jama.2020.1097","volume":"323","author":"AL Phelan","year":"2019","unstructured":"Phelan, A. L., Katz, R. & Gostin, L. O. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 323, 709\u2013710 (2019).","journal-title":"JAMA"},{"key":"66322_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579, 265\u2013269 (2020).","journal-title":"Nature"},{"key":"66322_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med."},{"key":"66322_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41577-020-00434-6","volume":"20","author":"M Jeyanathan","year":"2020","unstructured":"Jeyanathan, M. et al. Immunological considerations for COVID-19 vaccine strategies. Nat. Rev. Immunol. 20, 615\u2013632 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"66322_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012 (2020).","journal-title":"Cell"},{"key":"66322_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","volume":"184","author":"A Sette","year":"2021","unstructured":"Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184, 861\u2013880 (2021).","journal-title":"Cell"},{"key":"66322_CR7","doi-asserted-by":"publisher","first-page":"e883","DOI":"10.1016\/S2666-5247(23)00194-5","volume":"4","author":"E Stadler","year":"2023","unstructured":"Stadler, E. et al. Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis. Lancet Microbe 4, e883\u2013e892 (2023).","journal-title":"Lancet Microbe"},{"key":"66322_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","volume":"584","author":"DF Robbiani","year":"2020","unstructured":"Robbiani, D. F. et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 584, 437\u2013442 (2020).","journal-title":"Nature"},{"key":"66322_CR9","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","volume":"23","author":"P Moss","year":"2022","unstructured":"Moss, P. The T cell immune response against SARS-CoV-2. Nat. Immunol. 23, 186\u2013193 (2022).","journal-title":"Nat. Immunol."},{"key":"66322_CR10","doi-asserted-by":"publisher","first-page":"eabo1303","DOI":"10.1126\/sciimmunol.abo1303","volume":"7","author":"S Vardhana","year":"2022","unstructured":"Vardhana, S., Baldo, L., Morice, W. G. 2nd & Wherry, E. J. Understanding T cell responses to COVID-19 is essential for informing public health strategies. Sci. Immunol. 7, eabo1303 (2022).","journal-title":"Sci. Immunol."},{"key":"66322_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41577-022-00716-1","volume":"22","author":"SJ Kent","year":"2022","unstructured":"Kent, S. J. et al. Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?. Nat. Rev. Immunol. 22, 387\u2013397 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"66322_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.186078","volume":"9","author":"SI Ramirez","year":"2024","unstructured":"Ramirez, S. I. et al. Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2. JCI Insight 9, e186078 (2024).","journal-title":"JCI Insight"},{"key":"66322_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","volume":"22","author":"A Nelde","year":"2020","unstructured":"Nelde, A. et al. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition. Nat. Immunol. 22, 74\u201385 (2020).","journal-title":"Nat. Immunol."},{"key":"66322_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168 (2020).","journal-title":"Cell"},{"key":"66322_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.immuni.2020.11.004","volume":"53","author":"AS Shomuradova","year":"2020","unstructured":"Shomuradova, A. S. et al. SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors. Immunity 53, 1245\u20131257 (2020).","journal-title":"Immunity"},{"key":"66322_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41591-020-01143-2","volume":"27","author":"I Schulien","year":"2021","unstructured":"Schulien, I. et al. Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells. Nat. Med. 27, 78\u201385 (2021).","journal-title":"Nat. Med."},{"key":"66322_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciac278","volume":"75","author":"IA Molodtsov","year":"2022","unstructured":"Molodtsov, I. A. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific T cells and antibodies in coronavirus disease 2019 (COVID-19) protection: a prospective study. Clin. Infect. Dis. 75, e1\u2013e9 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"66322_CR18","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2022.03.022","volume":"185","author":"V Naranbhai","year":"2022","unstructured":"Naranbhai, V. et al. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals. Cell 185, 1259 (2022).","journal-title":"Cell"},{"key":"66322_CR19","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","volume":"34","author":"OW Ng","year":"2016","unstructured":"Ng, O. W. et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine 34, 2008\u20132014 (2016).","journal-title":"Vaccine"},{"key":"66322_CR20","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.chom.2021.05.010","volume":"29","author":"A Grifoni","year":"2021","unstructured":"Grifoni, A. et al. SARS-CoV-2 human T cell epitopes: adaptive immune responses against COVID-19. Cell Host Microbe 29, 1076\u20131092 (2021).","journal-title":"Cell Host Microbe"},{"key":"66322_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12985-023-01968-6","volume":"20","author":"W Wu","year":"2023","unstructured":"Wu, W., Cheng, Y., Zhou, H., Sun, C. & Zhang, S. The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics. Virol. J. 20, 6 (2023).","journal-title":"Virol. J."},{"key":"66322_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2431","volume":"33","author":"F Maghsood","year":"2023","unstructured":"Maghsood, F. et al. SARS-CoV-2 nucleocapsid: biological functions and implication for disease diagnosis and vaccine design. Rev. Med. Virol. 33, e2431 (2023).","journal-title":"Rev. Med. Virol."},{"key":"66322_CR23","doi-asserted-by":"publisher","first-page":"109664","DOI":"10.1016\/j.celrep.2021.109664","volume":"36","author":"T Dangi","year":"2021","unstructured":"Dangi, T., Class, J., Palacio, N., Richner, J. M. & Penaloza MacMaster, P. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2. Cell Rep. 36, 109664 (2021).","journal-title":"Cell Rep."},{"key":"66322_CR24","doi-asserted-by":"publisher","first-page":"eabp9770","DOI":"10.1126\/sciadv.abp9770","volume":"8","author":"AD L\u00f3pez-Mu\u00f1oz","year":"2022","unstructured":"L\u00f3pez-Mu\u00f1oz, A. D., Kosik, I., Holly, J. & Yewdell, J. W. Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Sci. Adv. 8, eabp9770 (2022).","journal-title":"Sci. Adv."},{"key":"66322_CR25","doi-asserted-by":"publisher","first-page":"761173","DOI":"10.3389\/fmolb.2022.761173","volume":"9","author":"B Zhang","year":"2022","unstructured":"Zhang, B. et al. Comparing the nucleocapsid proteins of human coronaviruses: structure, immunoregulation, vaccine, and targeted drug. Front. Mol. Biosci. 9, 761173 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"66322_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2164219","volume":"12","author":"H Yu","year":"2023","unstructured":"Yu, H., Guan, F., Miller, H., Lei, J. & Liu, C. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development. Emerg. Microbes Infect. 12, e2164219 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"66322_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N Le Bert","year":"2020","unstructured":"Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584, 457\u2013462 (2020).","journal-title":"Nature"},{"key":"66322_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42430-z","volume":"14","author":"C Choy","year":"2023","unstructured":"Choy, C. et al. SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors. Nat. Commun. 14, 6725 (2023).","journal-title":"Nat. Commun."},{"key":"66322_CR29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","volume":"54","author":"KE Lineburg","year":"2021","unstructured":"Lineburg, K. E. et al. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses. Immunity 54, 1055\u20131065 (2021).","journal-title":"Immunity"},{"key":"66322_CR30","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.immuni.2021.04.009","volume":"54","author":"THO Nguyen","year":"2021","unstructured":"Nguyen, T. H. O. et al. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity 54, 1066\u20131082 (2021).","journal-title":"Immunity"},{"key":"66322_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-021-01084-z","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng, Y. et al. An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. Nat. Immunol. 23, 50\u201361 (2022).","journal-title":"Nat. Immunol."},{"key":"66322_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41586-021-04232-5","volume":"601","author":"JS Heitmann","year":"2022","unstructured":"Heitmann, J. S. et al. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity. Nature 601, 617\u2013622 (2022).","journal-title":"Nature"},{"key":"66322_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40758-0","volume":"14","author":"JS Heitmann","year":"2023","unstructured":"Heitmann, J. S. et al. Phase I\/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency. Nat. Commun. 14, 5032 (2023).","journal-title":"Nat. Commun."},{"key":"66322_CR34","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.cell.2023.04.007","volume":"186","author":"CM Arieta","year":"2023","unstructured":"Arieta, C. M. et al. The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection. Cell 186, 2392\u20132409 (2023).","journal-title":"Cell"},{"key":"66322_CR35","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","volume":"21","author":"Y Peng","year":"2020","unstructured":"Peng, Y. et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336\u20131345 (2020).","journal-title":"Nat. Immunol."},{"key":"66322_CR36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","volume":"53","author":"AP Ferretti","year":"2020","unstructured":"Ferretti, A. P. et al. Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53, 1095\u20131107 (2020).","journal-title":"Immunity"},{"key":"66322_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.20040638","volume":"200","author":"D Meyer-Olson","year":"2004","unstructured":"Meyer-Olson, D. et al. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 200, 307\u2013319 (2004).","journal-title":"J. Exp. Med."},{"key":"66322_CR38","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.3390\/cells10102646","volume":"10","author":"C Szeto","year":"2021","unstructured":"Szeto, C. et al. Molecular basis of a dominant SARS-CoV-2 spike-derived epitope presented by HLA-A*02:01 recognised by a public TCR. Cells 10, 2646 (2021).","journal-title":"Cells"},{"key":"66322_CR39","doi-asserted-by":"publisher","first-page":"101065","DOI":"10.1016\/j.jbc.2021.101065","volume":"297","author":"P Chaurasia","year":"2021","unstructured":"Chaurasia, P. et al. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein. J. Biol. Chem. 297, 101065 (2021).","journal-title":"J. Biol. Chem."},{"key":"66322_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27669-8","volume":"13","author":"D Wu","year":"2022","unstructured":"Wu, D. et al. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors. Nat. Commun. 13, 19 (2022).","journal-title":"Nat. Commun."},{"key":"66322_CR41","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1016\/j.cell.2022.07.002","volume":"185","author":"G Dolton","year":"2022","unstructured":"Dolton, G. et al. Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope. Cell 185, 2936\u20132951 (2022).","journal-title":"Cell"},{"key":"66322_CR42","doi-asserted-by":"publisher","first-page":"103035","DOI":"10.1016\/j.jbc.2023.103035","volume":"299","author":"D Wu","year":"2023","unstructured":"Wu, D., Efimov, G. A., Bogolyubova, A. V., Pierce, B. G. & Mariuzza, R. A. Structural insights into protection against a SARS-CoV-2 spike variant by T cell receptor diversity. J. Biol. Chem. 299, 103035 (2023).","journal-title":"J. Biol. Chem."},{"key":"66322_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"66322_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev.immunol.23.021704.115658","volume":"24","author":"MG Rudolph","year":"2006","unstructured":"Rudolph, M. G., Stanfield, R. L. & Wilson, I. A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24, 419\u2013466 (2006).","journal-title":"Annu. Rev. Immunol."},{"key":"66322_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pro.2181","volume":"22","author":"BG Pierce","year":"2013","unstructured":"Pierce, B. G. & Weng, Z. A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes. Protein Sci. 22, 35\u201346 (2013).","journal-title":"Protein Sci."},{"key":"66322_CR46","doi-asserted-by":"publisher","first-page":"D604","DOI":"10.1093\/nar\/gkae840","volume":"53","author":"V Lin","year":"2025","unstructured":"Lin, V. et al. TCR3d 2.0: expanding the T cell receptor structure database with new structures, tools and interactions. Nucleic Acids Res. 53, D604\u2013D608 (2025).","journal-title":"Nucleic Acids Res."},{"key":"66322_CR47","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1006\/jmbi.1993.1648","volume":"234","author":"MC Lawrence","year":"1993","unstructured":"Lawrence, M. C. & Colman, P. M. Shape complementarity at protein\/protein interfaces. J. Mol. Biol. 234, 946\u2013950 (1993).","journal-title":"J. Mol. Biol."},{"key":"66322_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0065-3233(02)61001-0","volume":"61","author":"SJ Wodak","year":"2002","unstructured":"Wodak, S. J. & Janin, J. Structural basis of macromolecular recognition. Adv. Protein Chem. 61, 9\u201373 (2002).","journal-title":"Adv. Protein Chem."},{"key":"66322_CR49","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ni1502","volume":"8","author":"D Feng","year":"2007","unstructured":"Feng, D., Bond, C. J., Ely, L. K., Maynard, J. & Garcia, K. C. Structural evidence for a germline-encoded T cell receptor-major histocompatibility complex interaction \u2018codon\u2019. Nat. Immunol. 8, 975\u2013983 (2007).","journal-title":"Nat. Immunol."},{"key":"66322_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.immunol.26.021607.090421","volume":"26","author":"P Marrack","year":"2008","unstructured":"Marrack, P., Scott-Browne, J. P., Dai, S., Gapin, L. & Kappler, J. W. Evolutionarily conserved amino acids that control TCR-MHC interaction. Annu. Rev. Immunol. 26, 171\u2013203 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"66322_CR51","doi-asserted-by":"publisher","first-page":"pl2","DOI":"10.1126\/stke.2192004pl2","volume":"2004","author":"T Kortemme","year":"2004","unstructured":"Kortemme, T., Kim, D. E. & Baker, D. Computational alanine scanning of protein-protein interfaces. Sci. STKE 2004, pl2 (2004).","journal-title":"Sci. STKE"},{"key":"66322_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16755-y","volume":"11","author":"D Wu","year":"2020","unstructured":"Wu, D., Gallagher, D. T., Gowthaman, R., Pierce, B. G. & Mariuzza, R. A. Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen. Nat. Commun. 11, 2908 (2020).","journal-title":"Nat. Commun."},{"key":"66322_CR53","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq6150","volume":"10","author":"D Wu","year":"2024","unstructured":"Wu, D. et al. Structural characterization and AlphaFold modeling of human T cell receptor recognition of NRAS cancer neoantigens. Sci. Adv. 10, eadq6150 (2024).","journal-title":"Sci. Adv."},{"key":"66322_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe, S. & Buckland-Merrett, G. Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health. Glob. Chall. 1, 33\u201346 (2017).","journal-title":"Glob. Chall."},{"key":"66322_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41590-024-02051-0","volume":"26","author":"J Tian","year":"2025","unstructured":"Tian, J. et al. T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots. Nat. Immunol. 26, 265\u2013278 (2025).","journal-title":"Nat. Immunol."},{"key":"66322_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102096","volume":"24","author":"C Szeto","year":"2021","unstructured":"Szeto, C. et al. The presentation of SARS-CoV-2 peptides by the common HLA-A\u221702:01 molecule. iScience 24, 102096 (2021).","journal-title":"iScience"},{"key":"66322_CR57","doi-asserted-by":"publisher","first-page":"e4379","DOI":"10.1002\/pro.4379","volume":"31","author":"R Yin","year":"2022","unstructured":"Yin, R., Feng, B. Y., Varshney, A. & Pierce, B. G. Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants. Protein Sci. 31, e4379 (2022).","journal-title":"Protein Sci."},{"key":"66322_CR58","doi-asserted-by":"publisher","first-page":"e4865","DOI":"10.1002\/pro.4865","volume":"33","author":"R Yin","year":"2024","unstructured":"Yin, R. & Pierce, B. G. Evaluation of AlphaFold antibody-antigen modeling with implications for improving predictive accuracy. Protein Sci. 33, e4865 (2024).","journal-title":"Protein Sci."},{"key":"66322_CR59","doi-asserted-by":"publisher","first-page":"W569","DOI":"10.1093\/nar\/gkad356","volume":"51","author":"R Yin","year":"2023","unstructured":"Yin, R. et al. TCRmodel2: high-resolution modeling of T cell receptor recognition using deep learning. Nucleic Acids Res. 51, W569\u2013W576 (2023).","journal-title":"Nucleic Acids Res."},{"key":"66322_CR60","doi-asserted-by":"publisher","unstructured":"Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.10.04.463034 (2021).","DOI":"10.1101\/2021.10.04.463034"},{"key":"66322_CR61","unstructured":"DeepMind. AlphaFold v2.3.0 Technical Note https:\/\/github.com\/deepmind\/alphafold\/blob\/main\/docs\/technical_note_v2.3.0.md (2022)."},{"key":"66322_CR62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"66322_CR63","doi-asserted-by":"publisher","first-page":"e02002","DOI":"10.1128\/JVI.02002-20","volume":"95","author":"E Lee","year":"2021","unstructured":"Lee, E. et al. Identification of SARS-CoV-2 nucleocapsid and spike T-cell epitopes for assessing T-cell immunity. J. Virol. 95, e02002\u2013e02020 (2021).","journal-title":"J. Virol."},{"key":"66322_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00436-6","volume":"7","author":"F Chiuppesi","year":"2022","unstructured":"Chiuppesi, F. et al. Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates. NPJ Vaccines 7, 7 (2022).","journal-title":"NPJ Vaccines"},{"key":"66322_CR65","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1016\/S2666-5247(22)00027-1","volume":"3","author":"F Chiuppesi","year":"2022","unstructured":"Chiuppesi, F. et al. Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial. Lancet Microbe 3, e252\u2013e264 (2022).","journal-title":"Lancet Microbe"},{"key":"66322_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00321-8","volume":"6","author":"Q Jia","year":"2021","unstructured":"Jia, Q. et al. Replicating bacterium-vectored vaccine expressing SARS-CoV-2 membrane and nucleocapsid proteins protects against severe COVID-19-like disease in hamsters. NPJ Vaccines 6, 47 (2021).","journal-title":"NPJ Vaccines"},{"key":"66322_CR67","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4049\/jimmunol.2100421","volume":"207","author":"WE Matchett","year":"2021","unstructured":"Matchett, W. E. et al. Cutting edge: nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity. J. Immunol. 207, 376\u2013379 (2021).","journal-title":"J. Immunol."},{"key":"66322_CR68","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S2666-5247(21)00358-X","volume":"3","author":"JY Ahn","year":"2022","unstructured":"Ahn, J. Y. et al. Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults. Lancet Microbe 3, e173\u2013e183 (2022).","journal-title":"Lancet Microbe"},{"key":"66322_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32547-y","volume":"13","author":"JT Castro","year":"2022","unstructured":"Castro, J. T. et al. Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-nucleocapsid fusion protein. Nat. Commun. 13, 4831 (2022).","journal-title":"Nat. Commun."},{"key":"66322_CR70","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","volume":"185","author":"S Afkhami","year":"2022","unstructured":"Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185, 896\u2013915 (2022).","journal-title":"Cell"},{"key":"66322_CR71","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.4049\/jimmunol.165.5.2367","volume":"165","author":"J LeMaoult","year":"2000","unstructured":"LeMaoult, J. et al. Age-related dysregulation in CD8 T cell homeostasis: kinetics of a diversity loss. J. Immunol. 165, 2367\u20132373 (2000).","journal-title":"J. Immunol."},{"key":"66322_CR72","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1126\/science.1076064","volume":"298","author":"I Messaoudi","year":"2002","unstructured":"Messaoudi, I. et al. Direct link between MHC polymorphism, T cell avidity, and diversity in immune defense. Science 298, 1797\u20131800 (2002).","journal-title":"Science"},{"key":"66322_CR73","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ni.2342","volume":"13","author":"H Chen","year":"2012","unstructured":"Chen, H. et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat. Immunol. 13, 691\u2013700 (2012).","journal-title":"Nat. Immunol."},{"key":"66322_CR74","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1084\/jem.20081127","volume":"206","author":"DA Price","year":"2009","unstructured":"Price, D. A. et al. Public clonotype usage identifies protective Gag-specific CD8+ T cell responses in SIV infection. J. Exp. Med. 206, 923\u2013936 (2009).","journal-title":"J. Exp. Med."},{"key":"66322_CR75","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1126\/science.aav5095","volume":"364","author":"GD Gaiha","year":"2019","unstructured":"Gaiha, G. D. et al. Structural topology defines protective CD8+ T cell epitopes in the HIV proteome. Science 364, 480\u2013484 (2019).","journal-title":"Science"},{"key":"66322_CR76","unstructured":"Raouraoua, N., Lensink, M. F. & Brysbaert, G. Massive sampling strategy for antibody-antigen targets in CAPRI round 55 with MassiveFold. Proteins (in press)."},{"key":"66322_CR77","unstructured":"Gowthaman, R., Park, M., Yin, R., Guest, J. D. & Pierce, B. G. AlphaFold and docking approaches for antibody-antigen and other targets: insights from CAPRI rounds 47-55. Proteins (in press)."},{"key":"66322_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch, W. XDS. Acta Crystallogr. D. Biol. Crystallogr. 66, 125\u2013132 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"66322_CR79","first-page":"240","volume":"50","author":"Collaborative Computational Project No. 4","year":"1994","unstructured":"Collaborative Computational Project No. 4 The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. Biol. Crystallogr. 50, 240\u2013255 (1994).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"66322_CR80","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1107\/S0907444903028956","volume":"60","author":"LC Storoni","year":"2004","unstructured":"Storoni, L. C., McCoy, A. J. & Read, R. J. Likelihood-enhanced fast rotation functions. Acta Crystallogr. D. Biol. Crystallogr. 60, 432\u2013438 (2004).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"66322_CR81","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1107\/S0907444912001308","volume":"68","author":"PV Afonine","year":"2012","unstructured":"Afonine, P. V. et al. Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. D. Biol. Crystallogr. 68, 352\u2013367 (2012).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"66322_CR82","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"66322_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav7517","volume":"4","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes. Sci. Immunol. 4, eaav7517 (2019).","journal-title":"Sci. Immunol."},{"key":"66322_CR84","doi-asserted-by":"publisher","first-page":"E4648","DOI":"10.1073\/pnas.1408549111","volume":"111","author":"S Roy","year":"2014","unstructured":"Roy, S. et al. Molecular basis of mycobacterial lipid antigen presentation by CD1c and its recognition by \u03b1\u03b2 T cells. Proc. Natl. Acad. Sci. USA 111, E4648\u2013E4657 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66322_CR85","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41586-022-05501-7","volume":"612","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 612, 771\u2013777 (2022).","journal-title":"Nature"},{"key":"66322_CR86","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh, K. & Standley, D. M. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol. Biol. Evol. 30, 772\u2013780 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"66322_CR87","doi-asserted-by":"publisher","first-page":"101684","DOI":"10.1016\/j.jbc.2022.101684","volume":"298","author":"D Wu","year":"2022","unstructured":"Wu, D., Gowthaman, R., Pierce, B. G. & Mariuzza, R. A. T cell receptors employ diverse strategies to target a p53 cancer neoantigen. J. Biol. Chem. 298, 101684 (2022).","journal-title":"J. Biol. Chem."},{"key":"66322_CR88","doi-asserted-by":"publisher","first-page":"18949","DOI":"10.1073\/pnas.1115898108","volume":"108","author":"F Khatib","year":"2011","unstructured":"Khatib, F. et al. Algorithm discovery by protein folding game players. Proc. Natl. Acad. Sci. USA 108, 18949\u201318953 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66322_CR89","doi-asserted-by":"publisher","first-page":"e0161879","DOI":"10.1371\/journal.pone.0161879","volume":"11","author":"S Basu","year":"2016","unstructured":"Basu, S. & Wallner, B. DockQ: a quality measure for protein-protein docking models. PLoS ONE 11, e0161879 (2016).","journal-title":"PLoS ONE"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66322-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:04:01Z","timestamp":1767020641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66322-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66322"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66322-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11457"}}